(193 days)
Not Found
No
The device description and performance studies focus on mechanical and material properties, with no mention of AI/ML terms or image processing.
No
The device is described as "accessories" used "with laser fibers during urological endoscopic procedures." It does not directly provide therapy but assists in procedures where a laser fiber might be used for therapy.
No
The device is described as "accessories used with laser fibers during urological endoscopic procedures," implying its role in facilitating therapeutic or interventional procedures rather than diagnosing conditions. The performance studies focus on non-clinical aspects like biocompatibility and bench testing, not diagnostic metrics.
No
The device description lists physical components (Sheaths, Obturators, etc.) and the performance studies include bench testing of physical properties (Bending Force Test, Flow Test), indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the accessories are used with laser fibers during urological endoscopic procedures. This describes a device used in vivo (within the body) during a surgical procedure, not a device used in vitro (outside the body) to examine specimens like blood, urine, or tissue.
- Device Description: The listed accessories (Sheaths, Obturators, Working Elements, etc.) are all components used to facilitate endoscopic procedures within the urinary tract.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting analytes, or providing diagnostic information based on laboratory testing.
Therefore, the KARL STORZ Urological Laser Accessories are surgical accessories used in a clinical setting, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The KARL STORZ Urological Laser Accessories are used with laser fibers during urological endoscopic procedures.
Product codes (comma separated list FDA assigned to the subject device)
GEX
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following non-clinical performance data were provided in support of the substantial equivalence determination.
Biocompatibility testing
The system complies with the following standards:
◦ ISO 10993-1: Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process
◦ ISO 10993-2: Biological evaluation of medical devices - Part 2: Animal welfare requirements
◦ ISO 10993-5: Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
◦ ISO 10993-10: Biological evaluation of medical devices – Part 10: Tests skin sensitization
◦ ISO 10993-11: Biological evaluation of medical devices – Part 11: Tests for systemic toxicity
◦ ISO 10993-12: Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
ISO 10993-18: Biological evaluation of medical devices - Part 18: Chemical characterization of materials ISO 10993-23 Biological evaluation of medical devices - Part 23: Tests for irritation 2021
Reprocessing Validation Summary
The reprocessing data submitted complies with the following standards: ISO 14937: Sterilization of health care products — General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices ISO 17665-1: Sterilization of health care products - Moist heat - Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices AAMI TIR 30:2011: A compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable medical devices. ASTM F3208-17, 2017: Standard Guide for Selecting Test Soils for Validation of Cleaning Methods for Reusable Medical Devices ISO 15883-5: Washer Disinfectors – Test soils and methods for demonstrating cleaning efficacy
Bench Performance Testing
Additional bench testing was performed to ensure the device met its design specifications and is substantially equivalent to its predicate device.
System Interlocking Test
Flow Test (comparative)
Bending Force Test
Clinical performance data: Clinical testing was not required to demonstrate the substantial equivalence to the predicate device. Non-clinical bench testing was sufficient to assess safety and effectiveness and to establish the substantial equivalence of the modifications.
Conclusion: The conclusions drawn from the non-clinical performance data demonstrated that the subject device is as safe as and as effective as the predicate device. As such, we concluded that the substantial equivalence of the subject and the predicate device has been met, and the differences between the subject and the predicate device do not raise new questions of safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 8, 2023
Karl Storz SE & CO. KG % Emily Rhiel Regulatory Affairs Specialist KARL STORZ Endoscopy-America, Inc. 2151 E. Grand Avenue El Segundo, CA 90245
Re: K230535
Trade/Device Name: KARL STORZ Urological Laser Accessories Regulation Number: 21 CFR§ 878.4810 Regulation Name: Laser Surgical Instrument for use in General and Plastic Surgery and in Dermatology Regulatory Class: II Product Code: GEX Dated: August 4, 2023 Received: August 7, 2023
Dear Emily Rhiel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Mark J. Antonino -S
Mark J. Antonino, M.S. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K230535
Device Name
KARL STORZ Urological Laser Accessories
Indications for Use (Describe)
The KARL STORZ Urological Laser Accessories are used with laser fibers during urological endoscopic procedures.
The above indications are applicable to the following model numbers:
| 27026 VA |
|---|
| 27026 VI |
| 27026 VIL |
| 27026 OV |
| 27026 VS |
| 27040 SL |
| 27040 SD |
| 27050 SL |
| 27050 SC |
| 27040 ХА |
| 27040 XAL |
| PV27040 XAL-1 |
| 27050 CA |
| 27050 XA |
| 27056 LA |
| 27056 LB |
| 27056 LE |
| 27056 EA |
| 27056 EB |
| 27056 EC |
| 27056 ED |
| 27068 CD |
| 27050 VL |
| 27040 OC |
| 27048 CK |
| 27050 BE |
| 27050 BK |
| 27051 B |
| 27500 |
| 27502 |
| 27026 VY |
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
] Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/0 description: The image contains the logo for Karl Storz Endoskope. The word "STORZ" is in large, bold, blue letters on the top line. The words "KARL STORZ - ENDOSKOPE" are in smaller, bold, blue letters on the second line.
510(k) Summary
This 510(k) Summary is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and 21 CFR 807.92 and the FDA guidance document titled "The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]" issued on July 28, 2014. All data included in this document is accurate and complete to the best of KARL STORZ SE & Co. KG knowledge.
5
| Indications for Use: | The KARL STORZ Urological Laser Accessories are used with laser fibers
during urological endoscopic procedures. | | |
|--------------------------|--------------------------------------------------------------------------------------------------------------------|---------------|----------------------------------------------|
| Model Numbers: | Accessory Type | Model Number | Description |
| Cystoscope Accessories | | | |
| | Sheaths | 27026 VA | Outer Sheath, 23 Fr. |
| | | 27026 VI | Inner Sheath, with 7.5Fr. working
channel |
| | | 27026 VIL | Inner Sheath |
| | Obturators | 27026 OV | Obturator, 23 Fr. |
| | | 27026 VS | Visual Obturator |
| Resectoscope Accessories | | | |
| | Sheaths | 27040 SL | Resectoscope Sheath, 26 Fr. |
| | | 27040 SD | Resectoscope Sheath, 26 Fr. |
| | | 27050 SL | Resectoscope Sheath, 26 Fr. |
| | | 27050 SC | Resectoscope Sheath, 26 Fr. |
| | | 27040 XA | Inner Sheath for 27040 SD/SL |
| | | 27040 XAL | Inner Tube for 27040 SD/SL |
| | | PV27040 XAL-1 | Inner Tube |
| | | 27050 CA | Inner Sheath for 27050 SC |
| | | 27050 XA | Inner Sheath for 27050 SL |
| | Working
Elements | 27056 LA | Working Element |
| | | | 27056 LB |
| | | | 27056 LE |
| | Guiding Probes | 27056 EA | LASER Guide Probe, 0.8 mm |
| | | | 27056 EB |
| | | | 27056 EC |
| | | | 27056 ED |
| | Telescope Bridge | 27068 CD | Telescope Bridge |
| | Working Insert | 27050 VL | LASER Working Insert |
| | Obturators | 27040 OC | Standard Obturator |
| | | | 27048 CK |
| | | | 27050 BE |
| | | | 27050 BK |
| | | | 27051 B |
| Compatible Components | | | |
| | LUER-Lock Tube | 27500 | LUER-Lock Tube Connector |
| | Connectors | 27502 | LUER-Lock Tube Connector |
| | Adaptor | 27026 VY | LASER Cystoscope Adaptor |
6
| | Technological
Characteristics: | Subject Device
KARL STORZ Urological
Laser Accessories | Predicate Device
KARL STORZ Laser
Accessories K942786 |
|-----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|
| | System
Components | Sheath; obturator; working
element; guide probe;
working insert; bridge; laser
adaptor; LUER-Lock tube
connector | Sheath; obturator;
cannulae; endoscopes;
adaptor; bridge; deflection
device; backstop; protector |
| | Irrigation
and
Aspiration | Continuous flow | Same as subject |
| | Sheath | Diameter: 23.5 – 27.6Fr.
Length: 216.5 – 239mm | Diameter range: 21 – 24Fr
Length: 235 – 260.5mm |
| | Obturator | Diameter: 19.9 – 21Fr.
Length: 249.5 – 311.7mm | Diameter: 17.9 – 21.15Fr.
Length: 246.5 – 377.8mm |
| | Laser Guide
Probe | Length: 342.7mm-
345.7mm | N/A |
| | Working
Element | Diameter: 1 x 4.4mm, 1x
2.5mm
Length: 2x 4.4mm | N/A |
| | Telescope
Bridge | Number of channels: 1 | Number of channels: 1 – 2 |
| Non-Clinical
Performance Data: | The following non-clinical performance data were provided in support of
the substantial equivalence determination.
Biocompatibility testing
The system complies with the following standards:
◦ ISO 10993-1: Biological evaluation of medical devices – Part 1:
Evaluation and testing within a risk management process
◦ ISO 10993-2: Biological evaluation of medical devices - Part 2:
Animal welfare requirements
◦ ISO 10993-5: Biological evaluation of medical devices - Part 5:
Tests for in vitro cytotoxicity
◦ ISO 10993-10: Biological evaluation of medical devices – Part 10:
Tests skin sensitization | | |
| | ◦ ISO 10993-11: Biological evaluation of medical devices – Part 11:
Tests for systemic toxicity
◦ ISO 10993-12: Biological evaluation of medical devices - Part 12:
Sample preparation and reference materials | | |
7
| | ISO 10993-18: Biological evaluation of medical devices - Part 18: Chemical characterization of materials ISO 10993-23 Biological evaluation of medical devices - Part 23: Tests for irritation 2021 Reprocessing Validation Summary
The reprocessing data submitted complies with the following standards: ISO 14937: Sterilization of health care products — General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices ISO 17665-1: Sterilization of health care products - Moist heat - Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices AAMI TIR 30:2011: A compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable medical devices. ASTM F3208-17, 2017: Standard Guide for Selecting Test Soils for Validation of Cleaning Methods for Reusable Medical Devices ISO 15883-5: Washer Disinfectors – Test soils and methods for demonstrating cleaning efficacy Bench Performance Testing
Additional bench testing was performed to ensure the device met its design specifications and is substantially equivalent to its predicate device. System Interlocking Test Flow Test (comparative) Bending Force Test |
|-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Clinical
Performance Data: | Clinical testing was not required to demonstrate the substantial equivalence to the predicate device. Non-clinical bench testing was sufficient to assess safety and effectiveness and to establish the substantial equivalence of the modifications. |
| Conclusion: | The conclusions drawn from the non-clinical performance data demonstrated that the subject device is as safe as and as effective as the predicate device. As such, we concluded that the substantial equivalence of the subject and the predicate device has been met, and the differences between the subject and the predicate device do not raise new questions of safety and effectiveness. |